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Introduction
Curcumin (Cu) is a polyphenolic compound obtained from the dietary spice turmeric found in the Asian plant Curcuma longa. Due to its variety of biological properties such as anti-inflammatory, analgesic, potent antioxidant capacity (Aftab & Vieira, 2009; Ak & Gülçin, 2008) , antimicrobial (Zorofchian Moghadamtousi et al., 2014) and anticarcinogenic (Perrone D, Ardito F,Giannatempo G, Dioguardi M,Troiano G, Lo Russo L, De Lillo A, Laino L, 2015) , it has been used for centuries as dietary supplement and medicine (Gupta, Patchva, & Aggarwal, 2013; R.A. Sharma, Gescher, & Steward, 2005) . Several studies in animal models and humans have reported that no serious toxicity is observed when curcumin is administered even at high doses, and clinical phase I studies have shown an high tolerance to repeated ingestions of 12 g of curcumin per day (Anand, Kunnumakkara, Newman, & Aggarwal, 2007) . Many of the curcumin benefits are also found at a cellular level as regulator of cellular enzymes such as cyclooxygenase and glutathione S-transferases, immunomodulation, inhibitor of several cell signaling pathways, and cell-cell adhesion (R.A. Sharma et al., 2005) . Despite the established beneficial effects of curcumin as bioactive compound, curcumin has a poor aqueous solubility, intense staining color, and very low bioavailability (Anand et al., 2007;  A C C E P T E D M A N U S C R I P T milliliter) (Anand et al., 2007) . The major reasons causing such low gastrointestinal bioavailability of curcumin have been ascribed to poor absorption, chemical instability, rapid metabolism and systemic elimination, and accumulation within epithelial cells of the intestine (Anand et al., 2007; Wahlang, Pawar, & Bansal, 2011) . Furthermore, in the epathic and intestinal tissues of rats and humans, curcumin undergoes phase I and phase II metabolism (Hoehle, Pfeiffer, Sólyom, & Metzler, 2006 ; Ricky A. Sharma, Steward, & Gescher, 2007) , similar to in vitro investigations (Dempe et al., 2013; Pfeiffer et al., 2007) . A stepwise reduction of the olefinic double bonds of curcumin takes place in the phase I metabolism leading to tetrahydro-, hexahydro-, and octahydro-curcumin metabolites.
A further biotransformation of curcumin and its metabolites involves the conjugation to glucuronic acid, sulfate, and glutathione under cell-free conditions and also in human Caco-2 cells (Usta et al., 2007) . Moreover, it has also been documented that curcumin undergoes degradation in aqueous solution and at neutral pH, and hydrolyzed under alkaline pH (Tønnesen & Karlsen, 1985; Y. J. Wang et al., 1997) .
In order to overcome some of the major drawbacks of curcumin, different promising strategies have been undertaken aiming a higher permeability, resistance to metabolic processes, and enhancement of its solubility. A wide range of adjuvants such as piperine (Shoba et al., 1998) , quercetin (Cruz-Correa et al., 2006) , epigallocatechin-3-gallate (EGCG) (Balasubramanian & Eckert, 2004 ) and genistein (Verma, Salamone, & Goldin, 1997) have been proposed to modulate the permeability of curcumin and to increase its bioavailability. More recently, a wide variety of nanoand micro-delivery systems such as nanoparticles (Lee et al., 2014) , micelles (Kocher, Schiborr, Behnam, & Frank, 2015; Schiborr et al., 2014) , liposomes, and phospholipid complexes (Cuomo et (Anand et al., 2007) . However, very few studies have been published reporting improved delivery properties of curcumin-loaded systems. Nanoencapsulation of curcumin using natural and synthetic polymers (Lee et al., 2014) and liposomal nanoparticles have been the most explored strategies because of their suitability for the encapsulation of a highly hydrophobic compound like curcumin, the prevention of curcumin degradation processes, and the enhancement of curcumin chemical stability. Lately, mucoadhesive nanostructured lipid carriers (NLCs) coated with polyethylene glycol 400 (PEG400) and polyvinyl alcohol (PVA) have been employed as a candidate system for oral delivery of curcumin (Chanburee & Tiyaboonchai, 2017) . The authors have demonstrated that polymer-coated curcumin-loaded NLCs improved curcumin water solubility more than 60-folds, as compared to curcumin dispersion. In addition, curcumin was protected from degradation processes, and the in vitro apparent permeability (Papp) of curcumin across Caco-2 monolayers was higher than that obtained from uncoated NLCs (Chanburee & Tiyaboonchai, 2017) . Another approach to overcome the low curcumin oral bioavailability has been proposed by Frank et al.(Frank et al., 2017) .
The preparation of nanoscaled micellar formulations based on Tween 80 for curcumin delivery has revealed an increase on the apparent permeability through the intestinal barrier, resulting in a Papp value of 2.11x10 -6 cm/s, compared to a Papp value of 0.56x10 -6 cm/s for free native curcumin (Frank et al., 2017) . Furthermore, curcumin has been also encapsulated within electrospun fibers as delivery carriers, developed using phospholipid (Shekarforoush, Mendes, Baj, Beeren, & Chronakis, 2017) , as well as biopolymers such as gelatin (Deng, Kang, Liu, Feng, & Zhang, 2017) and blends of amaranth protein isolatepullulan (Blanco-Padilla, López-Rubio, Loarca-Piña, Gómez-Mascaraque, & Mendoza, 2015) .
Electrospun fibers hold great promises as oral delivery systems. The large surface to volume ratio, the tunable surface functionality as well as the high encapsulation efficiency of the electrospun fibers, favor the diffusion and the dissolution rate of the bioactive compounds, and thus enhance their delivery. (Ignatious, Sun, Lee, & Baldoni, 2010) (Li, Kanjwal, Lin, & Chronakis, 2013) . However, the delivery of the bioactive compounds at the intestine using electrospun fibers has not been assessed.
Furthermore, the Caco-2 cell model is used frequently to mimic the epithelial layer in the small intestine, and thus to evaluate the absorption of bioactive compounds in vitro assays (Artursson, Palm, & Luthman, 2001) . The Caco-2 cells, which are originally from a human colon cell line, can polarize and express receptors that resemble the intestinal absorptive cells found in the small intestine when cultured under specific conditions (Pinto et al., 1983) . In vitro permeability studies have been employed the Caco-2 cells model, to assess the cytotoxicity and the permeation of bioactive compounds such as intestinal absorption of peptide drugs (Araújo & Sarmento, 2013) (Araújo & Sarmento, 2013) . To the best of our knowledge, only few studies have assessed the intestinal delivery properties of bioactive compounds encapsulated within electrospun nanofibers using the Caco-2 cells model. A recent study from our group using a Caco-2 cell permeability assay found that electrospun fish sarcoplasmic proteins (FSP) nanofibers could be used as novel oral delivery system of biopharmaceuticals (Stephansen, García-Díaz, Jessen, Chronakis, & Nielsen, 2015) . Lin et al. also studied the anticancer efficiency of magnetic electrospun chitosan nanofibers by assessing the Caco-2 cell viability. It was found, that magnetic electrospun chitosan nanofibers have a potential therapeutic modality in tumor administration (Lin, Lin, & Lin, 2012) .
Chitosan is a cationic polysaccharide consisting of N-acetyl glucosamine (GlcNAc) and glucosamine (GlcN), and it has been widely used in the food, pharmaceutical and biomedical fields
because of its biocompatibility, biodegradability, and mucoadhesivity (Borchard et al., 1996) . One of the most interesting properties is the ability of chitosan to enhance gastrointestinal drug absorption (Portero, Remuñán-López, & Nielsen, 2002) . However, the chemical stability of chitosan is limited to a basic environment such as in the intestine and colon, whereas in neutral environments the polymer loses its charge and precipitate resulting in an ineffective absorption enhancer (Kowapradit et al., 2010) . In order to chemically stabilize chitosan for applications that demands enhanced drug absorption, chitosan derivatives such as water-soluble quaternary ammonium chitosan (Kowapradit et al., 2010) , and chitosan-glutamate (Portero et al., 2002) , have been synthesized.
Alternatively, stable polyelectrolyte complexes of chitosan with xanthan have showed favorable properties as intestinal delivery systems. For instance, xanthan-chitosan hydrogels (Fukuda, Peppas, & McGinity, 2006; Merlusca, Plamadeala, Girbea, & Popa, 2016; Popa, Novac, Profire, Lupusoru, & Popa, 2010; Sanem Argin-Soysala, Peter Kofinas, 2009 ) and xanthan-chitosan nanoparticles (Kulkarni, Wakte, & Naik, 2015) have been studied as oral delivery carriers for a range of drug and bioactive compounds.
In the present study, we report the formation of electrospun xanthan-chitosan nanofibers as an encapsulation and delivery system of curcumin. The resulting curcumin-loaded nanofibers were incubated with Caco-2 cells, and the cell viability, transepithelial transport and permeability properties across cell monolayers were investigated. A consistent enhancement of the in vitro intestinal absorption of curcumin across cell monolayers was observed when the polyphenol was loaded into xanthan-chitosan nanofibers compared to the free curcumin. The electrical conductivity of xanthan, chitosan and xanthan-chitosan, and xanthan-chitosancurcumin solutions was determined using WTW LF323-B conductivity meter (WTW GmbH, Weilheim, Germany). All measurements were carried out at room temperature (25 ± 2 °C) in triplicate for each sample.
Materials and Methods

Electrospinning setup
The electrospinning setup included a high voltage generator (ES50P-10W, Gamma High Voltage Research, Inc., USA) to provide a voltage of 25 kV, and a syringe pump (New Era Pump Systems, Inc., USA) to feed the xanthan-chitosan and curcumin mixtures at a flow rate of 0.01 mL/min. A 21 G needle (Proto Advantage, Canada) with inner diameter 0.813 mm was used. Nanofibers were collected on a steel plate covered with aluminium foil placed at a distance of 10 cm from the edge of the needle. The electrospinning process was carried out at ambient conditions and samples were stored in an exicator until further analysis.
Morphology
The morphology of electrospun nanofibers was monitored using a Quanta FEG 3D scanning electron microscope (SEM) as described by Shekarforoush et al. (Shekarforoush, Faralli, Ndoni, . Briefly, a small amount of fibers was attached on SEM specimen by a double-sided carbon adhesive tape, and sputter coated with 6 nm of gold layer (Leica Coater ACE 200). Image J software (National Institute of Health, USA) was used to analyse the average diameter of the nanofibers (measured at 100 different points for each image).
Encapsulation efficiency
The encapsulation efficiency of Cu within X-Ch electrospun nanofibers was determined by extracting the Cu from the fibers using methanol in a sonication bath for 30 min, and collecting the amount of loaded curcumin from supernatants after centrifugation at 4500 rpm for 15 min. The concentration of curcumin in the supernatant was determined using a UV-vis spectrometry (Nanodrop OneC, Thermo Fisher Scientific, Roskilde, DK), by recording its absorbance at 280 and 420 nm.
Standard curves for curcumin were prepared with concentrations ranging from 0-100 μg/mL. The encapsulation efficiency was calculated using the following equation:
2.6. In vitro release of curcumin
The in vitro release of curcumin from xanthan-chitosan nanofibers was evaluated by suspending 3.0 mg of X-Ch-Cu fibers in 2 mL pre-warmed HBSS at pH 6.5 and pH 7.4, respectively. The curcumin release was conducted for a time interval of 8 h at 37 °C with continuous mild agitation using an orbital shaker (100 rpm). Supernatant aliquots were withdrawn and analyzed by UV-vis spectrometry by recording the curcumin absorption at 280 and 420 nm. The cumulative amount of curcumin released from X-Ch-Cu nanofibers was then considered as the maximum releasable curcumin from the nanofibers structure.
Caco-2 cell culture and subculture Caco-2 cells were routinely seeded at a concentration of 1.0 x 10 5 cells/mL in T-75 cm 2 flasks and incubated at 37 °C in a humidified atmosphere of 5% CO2. The complete cell medium consisted of high glucose DMEM containing 10% heat-inactivated FBS, 2 mM L-glutamine, 1% nonessential amino acids, 100 U/mL penicillin, and 100 µg/mL streptomycin. The medium was renewed every second day until cells reached approximately 90% confluence. Cells were passaged at a subcultivation ratio of 1:4 by treatment with 0.25% trypsin -0.53 mM EDTA solution for 10 min at 37 °C. After trypsinization, the cells were suspended in complete growth medium and centrifuged for 5 min at 1000 rpm. After supernatant removal, the pellet was suspended in the growth medium and the cell concentration was determined with ORFLO Moxi Z Mini Automated Cell Counter using Type S cassette (Biofrontier Technology, Singapore). All Caco-2 cells were used between passages 6 -12.
Compounds and electrospun nanofibers used for the cell studies
Xanthan-chitosan (X-Ch) and curcumin-loaded xanthan-chitosan (X-Ch-Cu) electrospun nanofibers were tested with Caco-2 cells to evaluate their toxicity and to determine the apparent permeability coefficient (Papp) of curcumin loaded into the nanofibers, and as free compound. Before testing the nanofibers with Caco-2 cells, the collected fibers were kept under air stream for 3 days allowing complete formic acid evaporation.
Besides curcumin, the transepithelial transport of fluorescein (FLUO) and Lucifer yellow (LY) across
Caco-2 cell monolayers were also investigated as markers for intestinal epithelial permeability and integrity. The physicochemical properties and the expected mechanisms involved on molecules permeation across Caco-2 monolayers are listed in Table 1 . (Berginc, Žakelj, Levstik, Uršič, & Kristl, 2007) f Results published by Hashimoto et al.(Hashimoto, Matsunaga, & Shimizu, 1994) A
cell viability assay
The in vitro Caco-2 cell viability after treatment with free curcumin (Cu), xanthan-chitosan nanofibers (X-Ch), and curcumin-loaded xanthan-chitosan nanofibers (X-Ch-Cu) was evaluated by using the MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium inner salt] colorimetric bioassay. A stock solution of 50 mM curcumin was prepared in 0.5 M NaOH and immediately diluted to 5 mM in PBS. The curcumin solution was filtered through sterile-filters (with a 0.22 µm pore size). In a 96-well plate, a concentration of 2.0 x 10 4 cells/100µL
were seeded in a complete growth medium and incubated for 2 days at 37 °C in a humidified atmosphere of 5% CO2. Then the cells were washed with PBS, and the complete medium was renewed. Caco-2 cells were incubated with free curcumin solution (150 and 500 µM), X-Ch nanofibers (0.5 mg), X-Ch-Cu nanofibers (0.5 mg), and PBS as a control. Caco-2 cells were incubated for one day at 37 °C in a humidified atmosphere of 5% CO2. The following day, the nanofibers were removed from the wells, cells were washed with PBS and the medium was renewed (100 µL). 20 µL MTS solution was added to each well under dark conditions. After 3 h incubation at 37 °C, the absorbance of the reduced MTS (formazan product) was recorded at 490 nm through a well plate reader (Wallac 1420 Victor2 Multilabel Counter, Perkin Elmer, Waltham, MA).
Transepithelial transport experiments
The transport of free fluorescein (FLUO), free lucifer yellow (LY), free curcumin (Cu), free curcumin in presence of xanthan-chitosan nanofibers (X-Ch + Cu), and curcumin-loaded xanthanchitosan nanofibers (X-Ch-Cu) across Caco-2 cell monolayers were investigated according to the protocol reported by Artursson et al. (Hubatsch, Ragnarsson, & Artursson, 2007) . The transepithelial transport experiments were performed in both apical-to-basolateral (AB, absorptive) and basolateral-
to-apical (BA, secretory) directions, under a proton gradient. In fact, in order to mimic the acidic microclimate of the small intestine, an apical pH of 6.5 and a basolateral pH of 7.4 were used. Briefly, 1.0 x 10 5 cells/insert were seeded onto pre-wetted 12-mm polycarbonate cell culture inserts (area of 1.12 cm 2 and a pore size of 0.4 µm). The apical and basolateral compartments were filled with 0.5 mL cell suspension and 1.5 mL complete medium, respectively. The Caco-2 cells plates were incubated overnight at 37 °C in a humidified atmosphere of 5% CO2. The day after, the growth medium was replaced in both compartments and the plates were incubated for 21 days at 37 °C in a humidified atmosphere of 5% CO2, renewing the complete growth medium every second day. For the AB transport experiments, donor solutions of fluorescein, lucifer yellow, and curcumin at a concentration of 11 mM, 9.57 mM, and 1.65 mM, respectively were prepared in sterile-filter HBSS at pH 6.5 buffered with 10 mM MES. Again, donor solutions of fluorescein, lucifer yellow, and curcumin at a concentration of 10.3 mM, 9 mM, and 1.55 mM, respectively were prepared in sterilefilter HBSS at pH 7.4 buffered with 25 mM HEPES to evaluate their BA transport across cell monolayers. X-Ch and X-Ch-Cu nanofibers have been also investigated, and 3.0 mg of nanofibers for AB transport and 9.0 mg of nanofibers for BA transport were used. After 21 days cell growth, the complete DMEM medium was removed from the Caco-2 cell monolayers and was replaced with HBSS at pH 6.5 and pH 7.4 at the apical and basolateral compartments, respectively. For the AB transport studies, 1.5 mL HBSS was used in the basolateral side and 0.55 mL of each donor solutions and/or nanofibers were added to the apical side. Immediately, 50 µL aliquots were withdrawn from each donor compartment (time=0). The aliquots were then withdrawn from the acceptor side at different time intervals, and the volume was replaced with fresh pre-warmed HBSS at pH 7.4 maintaining the well plates at 37 °C in a humidified atmosphere of 5% CO2. A final aliquot from the donor chamber was taken as last time point. BA transport studies were conducted by using 0.5 mL HBSS at pH 6.5 in the apical side, and 1.55 mL of donor solution and/or nanofibers in the basolateral
chamber. Again, a 50 µL aliquot was immediately withdrawn from the donor compartment (time=0), and the plates were kept at 37 °C in a humidified atmosphere of 5% CO2. At different time intervals, 50 µL aliquots from the acceptor compartment were collected and the volume was replaced with fresh pre-warmed HBSS at pH 6.5. A final aliquot was taken from the donor side at last time point. During the transport experiments, all cell media and solutions were pre-warmed at 37 °C. Each transport experiment was performed for a time interval of 8h, in triplicates (n=3). After 8 h transport studies both apical and basolateral chambers were washed twice with PBS, and cell monolayers were detached from the insert membrane with 0.25% trypsin -0.53 mM EDTA solution for 10 min at 37 °C. The collected Caco-2 cell lysates were centrifuged for 5 min at 1000 rpm and supernatants were discarded. Furthermore, the semipermeable membranes were carefully removed from the insert using a scalpel and collected into Eppendorf tubes in 500 µL HBSS at pH 6.5 (apical conditions). Cell pellets as well were re-suspended in 500 µL HBSS at pH 6.5 and both cells and membranes were sonicated for 3 h using an ultrasonic bath (Branson Ultrasonic Corp., VWR, Denmark). The collected samples were then centrifuged for 5 min at 10 000 rpm and the supernatants were analyzed by UVvis spectroscopy. The same procedure was used to quantify the amount of curcumin adsorbed (X-Ch + Cu) or encapsulated (X-Ch-Cu) into the nanofibers at the end of transport experiments. The tested nanofibers were removed from the donor chamber and suspended in 500 µL of HBSS (pH 6.5 for AB transport and pH 7.4 for BA transport). After sonication and centrifugation, the curcumin found in the supernatants was quantified by absorbance measurement.
Measurement of transepithelial electrical resis tance (TEER)
The Transepithelial Electrical Resistance (TEER) was measured at room temperature before and after permeability experiments with an epithelial volt-ohmmeter equipped with an STX2 "chopstick" electrodes (EVOM2™, World Precision Instruments, Sarasota, FL, USA). Before measuring the After transport experiments in both AB and BA directions, the amount of each compound in the apical and basolateral compartments was quantified by UV-vis spectrometry. Donor concentrations at time=0 (CD,t=0h), donor and acceptor concentrations at time=8h (CD,t=8h and CA,t=8h, respectively), compound concentrations remained within cell monolayer at time=8h (CCaco-2,t=8h), membrane filters at time=8h (Cinsert,t=8h), and adsorbed or encapsulated into nanofibers at time=8h (Cfibers,t=8h) were experimentally measured by UV-vis spectroscopy. Therefore, the mass balance of each compound was calculated as follow:
Mass balance values of >90% were found for all tested compounds.
2.14. Calculation of the apparent permeability coefficients Papp, AB and Papp, BA.
The absorptive apparent permeability coefficient (Papp, AB) and the secretory apparent permeability coefficient (Papp, BA) were determined according to the equation:
where, dC/dt (µM/s) is the change in concentration on the acceptor chamber over time; V (cm 3 ) is the volume of the solution in the acceptor compartment; A (cm 2 ) is the area of the semipermeable membrane; C0 (µM) is the initial concentration in the donor chamber. The results presented in this study were the averages of three experiments and were expressed as the mean ± standard deviation.
Results and Discussions
A C C E P T E D M A N U S C R I P T
Electrospinning of Xanthan -Chitosan nanofibers
Xanthan-Chitosan nanofibers were obtained by electrospinning mixtures of X at the concentration of 0.75% w/v with 3% w/v Ch dissolved in formic acid (Fig. 1) . The obtained nanofibrous structures are composed of individual, uniform and randomly oriented fibers with an average diameter of 750 ± 250 nm. Note that chitosan solution (3% w/v) in formic acid (without xanthan) could not be electrospun into fibers. The average diameter of electrospun xanthan-chitosan nanofibers slightly increased to 900 ± 440 nm with the addition of 2% w/v curcumin (Fig. 1) . The encapsulation efficiency of Cu within X-Ch nanofibers was 69.4±4.1%. Moreover, the X-Ch-Cu nanofibers remained stable in aqueous HBSS medium at different pH (6.5 and pH 7.4), due to the ability of oppositely charged xanthan-chitosan mixture to form ionically associated electrospun nanofibers, (Shekarforoush, Ajalloueian, Zeng, Mendes, Chronakis, 2018) .
The features of xanthan-chitosan-curcumin nanofibers were not further examined in the present study.
In vitro release study
The cumulative release profile of curcumin from the electrospun X-Ch nanofibers at two different pH (7.4 and 6.5) at 37 °C is shown in Fig. 2 
Caco-2 cell studies
In our previous studies, we have observed a significant effect on the permeation of a model protein (insulin) across Caco-2 cells upon contact with electrospun fish sarcoplasmic protein fibers (FSP) (Stephansen et al., 2015) . Encapsulation of insulin into the FSP fibers provided protection against chymotrypsin degradation (suitable for oral administration), and the interactions between fibers and epithelial cells led to opening of the tight junction, which promoted an increased transepithelial transport of insulin without compromising cellular viability (Stephansen et al., 2015) . This approach of using electrospun nanofibers is superior to the typical approach of administering solely nanoparticles for intestinal delivery of bioactives (typically nanoparticles are distributed over the entire surface, having a short retention time, and low bioactive penetration). The Caco-2 cell system has been recommended by the US Food and Drug Administration (FDA)
as being an established in vitro cell model for the prediction of oral drug absorption and drug transport mechanism across human differentiated epithelial cell monolayers (Artursson et al., 2001) . The human colon carcinoma cell line Caco-2 was chosen because of the many similar features with the intestinal epithelial cells. In fact, Caco-2 cells can slowly differentiates into monolayers forming microvilli and tight junctions at the apical side, and expressing brush border enzymes for phase I and phase II metabolism and transport proteins (Hubatsch et al., 2007; Naruhashi et al., 2011; Yee, 1997) .
In the present study, the Caco-2 cell system was selected as a tool to investigate the in vitro absorption and the transports (both apical-to-basolateral (AB) and basolateral-to-apical (BA)) of curcumin across cell monolayers.
Evaluation of cell viability
The viability of Caco-2 cells after 24-h treatment with free curcumin (Cu), Xanthan-Chitosan nanofibers (X-Ch), curcumin-loaded Xanthan-Chitosan nanofibers (X-Ch-Cu), and PBS was evaluated through MTS bioassay (Fig. 3) . The MTS tetrazolium compound is reduced by cells into a colored formazan product that is soluble in tissue culture medium and quantified recording its absorbance at 490 nm. This conversion is accomplished by dehydrogenase enzymes in metabolically active cells, therefore MTS conversion is directly proportional to the number of living cells (Cory, Owen, Barltrop, & Cory, 1991) . The incubation of Caco-2 cells with 0.5 mg X-Ch nanofibers, 0.5 mg X-Ch-Cu nanofibers, and free curcumin (Cu, 150 µM) was non-toxic to the cells, and cell viability was found to be ≥ 80%. By contrast, when cells were exposed to 500 µM free curcumin, the cell viability value was decreased to ~20%, indicating a concentration-dependent toxic effect of curcumin in cell viability. According to the encapsulation efficiency of curcumin into nanofibers and the in vitro release profile of curcumin from X-Ch-Cu nanofibers at pH 7.4, the amount of releasable when the passive transport of substances through tight junctions is involved (Srinivasan et al., 2015) .
Therefore, the AB and BA transepithelial transports of fluorescein (FLUO) and lucifer yellow (LY)
across Caco-2 monolayers under a proton gradient were investigated (Fig. 4) . The average of TEER values for Caco-2 cell monolayers measured at 37 °C was 422 ± 30 Ω cm 2 and the TEER values of Caco-2 cell monolayers before and after transport of FLUO and LY were found to be in the range of 350-500 Ω cm 2 (Fig. 4a) indicating an "intermediate" tightness of the gastrointestinal epithelium, as established by the GI epithelia classification based on TEER values (Amidon, Lee, & Topp, 2000) . Fig. 4b and 4c show the cumulative permeated amount of the two markers after apical-to-basolateral and basolateral-to-apical transport across Caco-2 cell monolayers in presence of a proton gradient (pH 6.5 in A and pH 7.4 in B), and the FLUO and LY distribution within the cell model system, respectively. The permeation of fluorescein across the monolayers increased over time and it was higher when a lower pH of the donor solution was used. In fact, after 8h the amount of fluorescein at the acceptor chamber was 20% and 12% for the AB and BA transport respectively, suggesting a pHdependent transport of fluorescein. Consequently, most of the fluorescein at the donor side was still found at time=8h (~78%), and this value was even higher for BA transport. Only small amounts of FLUO were detected within the cell lysate and insert membrane (0.74 and 0.58%, respectively).
Contrarily, the permeation of LY was weakly affected by pH and the cumulative amounts transferred across cell monolayers were less than 1.5% for both AB and BA transports, resulting in a highly poor
absorption of LY (98% of the initial donor concentration remained there). The values of the apparent permeability coefficients of FLUO were Papp,AB =9.52x10 -6 and Papp,BA =1.89x10 -6 cm/s, whereas much lower values were calculated for the LY transport: Papp,AB =6.26x10 -7 and Papp,BA =1.46x10 -7 cm/s (Fig. 4d) . These results demonstrate that the different physical-chemical properties of FLUO and LY are strongly reflected in their permeation across the cell monolayers and the transport mechanism involved in the absorption. The main features of a compound influencing its permeation are logP, pKa, molecular weight, and ionization (Table 1) (Camenisch, Folkers, & van de Waterbeemd, 1996) . Fluorescein is a small and lipophilic molecule (logPo/w =4.81) and possesses two ionization groups having a pKa1=4.36 and pKa2=6.38. By contrast, lucifer yellow is a small hydrophilic compound (logPo/w= -5.06) and has a pKa= -0.9. According to the results presented in Fig. 4 , Papp values of FLUO increased with the decreasing pH of the donor solution, at which the compound is ionized at a smaller extent, while the high hydrophilicity and ionization of LY prevent its absorption through cell monolayers. The apical membrane of polarized epithelial cell layers has a lipoid nature thus it restricts the transport of ions and hydrophilic molecules. Therefore, lipophilic compounds like FLUO, across the cell barrier through a passive transcellular transport following their pH partitioning into the apical membrane and diffusing through the cytoplasm reaching the basolateral membrane (Högerle & Winne, 1983) . For more hydrophilic compounds like LY, transcellular diffusion is often prevented and depending on the pKa of molecules at the donor pH, the transport of these solutes across epithelial cells can occur via tight junctions (paracellular transport).
In the light of these considerations, the results obtained from AB and BA transport of FLUO and LY suggested that the integrity and tightness of Caco-2 cell monolayers after 21 days were maintained, and further studies using X-Ch-Cu nanofibers have been investigated using this approach. 3.6. Caco-2 cell monolayers treatments
The low aqueous solubility, poor intestinal absorption and extensive metabolism and excretion are crucial parameters that affect curcumin bioavailability. In order to overcome some of these limiting factors, Xanthan-Chitosan electrospun nanofibers as curcumin delivery system were produced and investigated. In the present study, the restricted use of chitosan as an in vitro absorption enhancer in epithelial cell monolayers was overcome by mixing the chitosan with xanthan gum polysaccharide.
As reported by Dempe et al. (Dempe et al., 2013) , Caco-2 cell monolayers express the enzymes involved in phase I and II metabolism of curcumin. In fact, curcumin metabolites such as hexahydroand octahydro-curcumin, as well as their glucuronide and sulfate conjugates were identified as major metabolites at the donor and acceptor side (Dempe et al., 2013) . Thus, in the present study, the quantification of curcumin at the apical and basolateral side was conducted recording the absorbance of native curcumin at 420 nm, and also measuring the absorbance of curcumin metabolites at 280 nm, as suggested by Dempe et al. (Dempe et al., 2013) . Therefore, the data obtained for curcumin transepithelial transport studies, include the contribution of both transported native curcumin and its metabolites.
The 24 h exposure of Caco-2 cell monolayers to X-Ch and X-Ch-Cu nanofibers resulted in a cell viability >90% and ~80%, respectively (Fig. 3) . In addition to that, the incubation of cell monolayers with 150 µM free Cu and X-Ch-Cu nanofibers ended up to a comparable cell viability value,
indicating that the amount of curcumin loaded into the nanofibers was similar to the free curcumin (150 µM), and that the small decrement in cell viability (~80%) was attributed to the curcumin dose
and not to the presence of X-Ch nanofibers (>90%). In order to investigate the presumed enhancement of curcumin absorption across epithelial cell monolayers in presence of Xanthan-Chitosan nanofibers, the AB and BA transport of free Cu (Cu), X-Ch nanofibers + free Cu (X-Ch + Cu), and curcuminloaded X-Ch nanofibers (X-Ch-Cu) were performed ( Fig. 5a and b) . As depicted in the illustrations, the free curcumin and/or nanofibers were incubated at the donor chamber and the transported amount of curcumin was withdrawn from the acceptor side over a period of 8h under a proton gradient. The addition of Xanthan-Chitosan nanofibers to free curcumin was found to enhance curcumin permeation of nearly 2-fold compared to free curcumin alone, and such enhancement was even higher for X-Ch-Cu nanofibers reaching 3.4-fold. For X-Ch-Cu nanofibers, the total amount of curcumin transported across cell monolayers for AB and BA transports was 32.81% and 46.94% of the releasable curcumin, respectively. The observed slight reduction of TEER values for AB transport of X-Ch + Cu and X-Ch-Cu was found to be more pronounced for BA transport of X-Ch + Cu and X-Ch-Cu ( Fig. 5c and d) . Taken together, the observed results suggest that the presence of Xanthan-Chitosan nanofibers positively affect curcumin permeation since a 3-fold higher concentration of curcumin was detected in the acceptor chamber. The decrease in TEER values supports that the tight junctions were affected by the electrospun fibers, and direct contact between the fibers and cell monolayers. This is in agreement with our previous study on the permeation of a model protein (insulin) across Caco-2 cells upon contact with electrospun fish protein fibers (Stephansen, García-Díaz, Jessen, Chronakis, & Nielsen, 2015) . Indeed, we found that direct interaction between the nanofibers and the monolayer induces changes in the tight junctions, and thus an increase in permeation at local hot spots on the epithelial barrier. Moreover, the reduction of TEER values could be also attributed in part to the presence of chitosan within the electrospun nanofibers, which is responsible for the tight junctions opening, thus promoting paracellular transport. In addition to that, no cell-damaging was detected after 24 h treatment with X-Ch and X-Ch-Cu. In fact, the effect of Kowapradit et al., 2010) , and TEER measurements have shown that chitosan induces an immediate reduction of TEER in a dose-dependent effect on tight junction permeability. However, a recovery of TEER values in the time range of few hours up to one day could be observed after chitosan polymer solution removal (Borchard et al., 1996; Kowapradit et al., 2010) . In these studies, a paracellular transport of [ 14 C]-mannitol across Caco-2 monolayers was recorded only when a certain TEER threshold value was reached (Borchard et al., 1996) . The fate of curcumin during transepithelial transport in both AB and BA directions was monitored by quantifying (after 8 h) the amount of curcumin in the donor and acceptor side, Caco-2 cell lysate, insert membrane, and within X-Ch nanofibers. Fig. 6a shows the distribution of curcumin in the above-mentioned compartments when free Cu, X-Ch + Cu, and X-Ch-Cu nanofibers were incubated in the donor chamber. Although significant amounts of curcumin were still detected in the donor side after 8h transport, curcumin concentrations ≥10% of the donor initial concentration were detected in the acceptor side. Only small amounts of curcumin were found into cell lysate, < 3%, and insert membrane, < 1.5%, while considerable curcumin amounts remained loaded into X-Ch-Cu nanofibers even after 8h release (28% into X-Ch-Cu in the AB study, and 13% into X-Ch-Cu in the BA study).
Nevertheless, the proposed curcumin delivery system showed the highest amount of curcumin permeating the epithelial cell monolayers with a Papp, AB = 1.49x10 -5 cm/s and a Papp, BA = 7.00x10 -6 cm/s (Fig. 6c) , and a 2-fold permeability enhancement was measured when Xanthan-Chitosan nanofibers were added to a free curcumin solution in the donor side compared to free curcumin 
Conclusions
Uniform and homogeneous Xanthan-Chitosan nanofibers were fabricated using electrospinning processing and investigated as an encapsulation and delivery system of curcumin, a poor water soluble polyphenolic compound. It was found that X-Ch-Cu nanofibers remained stable in aqueous HBSS medium at different pH (6.5 and pH 7.4). Moreover, X-Ch-Cu nanofibers were incubated with Caco-2 cells, and cell viability, transepithelial transport and curcumin permeability properties across cell monolayers were investigated. After 24 h of incubation, the exposure of Caco-2 cell monolayers to X-Ch and X-Ch-Cu nanofibers resulted in a cell viability of >90% and ~80%, respectively. A 3.4-fold increase of curcumin permeability was observed in the presence of X-Ch fibers, in comparison with free-curcumin. The X-Ch nanofibers interacted with intestinal Caco-2 cells and caused tight junctions opening, demonstrated by a decrease in TEER values, which promoted increased transepithelial permeation of curcumin without compromising cellular viability. Hence, the interactions between electrospun fibers and the epithelial cells, could be used to promote increased uptake of bioactives. Furthermore, in vivo experiments are required to fully demonstrate the efficiency of these nanofibers for oral delivery applications of poorly water-soluble compounds at the gastrointestinal tract.
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